» Authors » Yohei Mano

Yohei Mano

Explore the profile of Yohei Mano including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 75
Citations 1316
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Sugimachi K, Shimagaki T, Tomino T, Onishi E, Mano Y, Iguchi T, et al.
Ann Gastroenterol Surg . 2024 Nov; 8(6):1118-1125. PMID: 39502730
Aims: Splenic vein occlusion (SpVO) due to a pancreatic tumor may result in the development of collateral circulation and left-sided portal hypertension. This study aimed to investigate the impact of...
2.
Shimagaki T, Sugimachi K, Mano Y, Onishi E, Iguchi T, Nakashima Y, et al.
Ann Gastroenterol Surg . 2023 Nov; 7(6):977-986. PMID: 37927935
Aim: This study was performed to investigate the relationship between the preoperative cachexia index (CXI) and long-term outcomes in patients who have undergone radical resection of pancreatic ductal adenocarcinoma (PDAC)....
3.
Mano Y, Sugimachi K, Shimagaki T, Tomino T, Onishi E, Lee L, et al.
Surg Case Rep . 2023 Sep; 9(1):173. PMID: 37773552
Background: Liver metastasis of pure squamous cell carcinoma (SCC) from pancreatic ductal adenocarcinoma has not been previously reported. Case Presentation: A 66-year-old man underwent a computed tomography scan 3 years...
4.
Shimagaki T, Sugimachi K, Mano Y, Tomino T, Onishi E, Taguchi K, et al.
Clin J Gastroenterol . 2023 Sep; 17(1):93-99. PMID: 37751079
Chronic expanding hematoma (CEH) is defined as a hematoma that grows slowly over a month or longer. CEH with a primary hepatic origin is extremely rare. An 85-year-old man presented...
5.
Shimagaki T, Sugimachi K, Mano Y, Tomino T, Onishi E, Nakashima Y, et al.
PLoS One . 2023 Jul; 18(7):e0288033. PMID: 37450554
Background: Pancreatic ductal adenocarcinoma (PDAC) often recurs early after radical resection, and such early recurrence (ER) is associated with a poor prognosis. Predicting ER is useful for determining the optimal...
6.
Uehara H, Ota M, Yamamoto M, Nakanoko T, Shin Y, Shiokawa K, et al.
Anticancer Res . 2023 Jan; 43(2):893-901. PMID: 36697095
Background/aim: Surgery for elderly patients with gastric cancer is becoming more common. However, the risk factors of the laparoscopic surgery for these patients are unknown, and thus it is difficult...
7.
Sugimachi K, Araki H, Saito H, Masuda T, Miura F, Inoue K, et al.
JGH Open . 2022 Dec; 6(12):854-863. PMID: 36514506
Background And Aim: The risk of hepatocellular carcinoma (HCC) persists in a condition of sustained virologic response (SVR) after hepatitis C virus (HCV) eradication. Comprehensive molecular analyses were performed to...
8.
Shimagaki T, Sugimachi K, Mano Y, Onishi E, Iguchi T, Uehara H, et al.
Ann Gastroenterol Surg . 2022 Nov; 6(6):813-822. PMID: 36338597
Aim: Oxaliplatin, an anticancer drug for advanced colorectal cancer, causes liver sinusoidal damage, sometimes with portal hypertension. We conducted a retrospective comparative study of the relationship of liver sinusoidal disorders...
9.
Shimagaki T, Sugimachi K, Mano Y, Onishi E, Tanaka Y, Sugimoto R, et al.
Surg Case Rep . 2022 Sep; 8(1):170. PMID: 36107353
Background: Undifferentiated embryonal sarcoma of the liver (UESL) is a rare malignant mesenchymal tumor that usually occurs in children and is rarely diagnosed in adults. Case Presentation: The case was...
10.
Sugiyama M, Uehara H, Shin Y, Shiokawa K, Fujimoto Y, Mano Y, et al.
Surg Today . 2021 Nov; 52(4):633-642. PMID: 34762175
Purpose: Selected patients with initially unresectable colorectal cancer (CRC) and liver metastases undergo conversion surgery after appropriate chemotherapy. The prognosis of these patients is good, with some even cured of...